| Molecule | Cat. No. | Product Name | 種 | Host | Structure | Purity | Activity | Size&Price |
|---|---|---|---|---|---|---|---|---|
| GIPR | HOTAvitag GIR-H82E3 | Biotinylated Human GIPR Protein, His,Avitag™ (MALS verified) | Human | HEK293 | ![]() | MALSSDS-PAGE | $450.00 25ug | |
| GIPR | Cynomolgus GIPR Protein, His Tag | Cynomolgus | HEK293 | ![]() | SDS-PAGE | $385.00 100ug | ||
| GIPR | Avitag GIR-C82E3 | Biotinylated Cynomolgus GIPR Protein, His,Avitag™ | Cynomolgus | HEK293 | ![]() | SDS-PAGE | $415.00 25ug | |
| GIPR | Human GIPR Protein, Fc Tag, low endotoxin (MALS & SPR verified) | Human | HEK293 | ![]() | MALSSDS-PAGE | $500.00 100ug | ||
| GIPR | Human GIPR Protein, His,Flag Tag (Detergent) | Human | HEK293 | ![]() | $805.00 20ug | |||
| GIPR | Human GIPR Protein, His Tag (MALS verified) | Human | HEK293 | ![]() | MALSSDS-PAGE | $500.00 100ug | ||
| GIPR | Human GIPR Protein (VLP) | Human | HEK293 | $620.00 20ug | ||||
| GIPR | Avitag GIR-H82F3 | Biotinylated Human GIPR Protein, Fc,Avitag™ | Human | HEK293 | ![]() | SDS-PAGE | $450.00 25ug |
| 英語名 | 研究コード | 研究開発ステージ | 会社 | 適応症 | 臨床試験 |
|---|---|---|---|---|---|
| AT-02 | AT-02 | Phase 2 Clinical | Attralus Inc | Immunoglobulin Light-chain Amyloidosis; Amyloidosis | 詳細 |
| Anti-CD33/anti-FcgammaRI bispecific antibody (UCSD) | Phase 1 Clinical | University Of California San Diego | Leukemia, Myeloid, Acute | 詳細 |
| 英語名 | 研究コード | 研究開発ステージ | 会社 | オリジナル製品名 | 最初に承認をした国 | 最初の適応症 | 最初に承認を受けた会社 | 承認された日付 | 適応症 | 臨床試験 |
|---|---|---|---|---|---|---|---|---|---|---|
| Imlifidase | Mac-1 | Approved | Hansamed Inc | Idefirix | EU | Rejection of renal transplantation | Hansa Biopharma Ab | 2020-08-25 | Rejection of renal transplantation; Kidney Diseases; Purpura, Thrombotic Thrombocytopenic; Rejection of organ transplantation; Renal Insufficiency, Chronic; Guillain-Barre Syndrome; Kidney Failure, Chronic | 詳細 |